REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today announced that Anastassios D. Retzios, Ph.D. has joined the Company in the newly created position of Vice President of Clinical Development, reporting to Gregory Turnbull, the Company’s Chief Executive Officer. Dr. Retzios has more than 18 years of experience in a wide range of clinical and regulatory matters, most recently as Director of Global Clinical Research and Development at Baxter BioScience. Previously he served in senior clinical positions at Questcor Pharmaceuticals and Alpha Therapeutic Corporation.
